P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA.
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000971676.94450.1b |
| _version_ | 1797280836272259072 |
|---|---|
| author | Yuelu Guo Kai Hu Xiaoyan Ke Teng Xu Shaomei Feng Peihao Zheng Lixia MA Fan Yang Hui Shi Biping Deng Liu Rui Zhonghua Fu |
| author_facet | Yuelu Guo Kai Hu Xiaoyan Ke Teng Xu Shaomei Feng Peihao Zheng Lixia MA Fan Yang Hui Shi Biping Deng Liu Rui Zhonghua Fu |
| author_sort | Yuelu Guo |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:46:57Z |
| format | Article |
| id | doaj.art-26fa0271729540ebbf5876a8c9a87ac4 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:46:57Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-26fa0271729540ebbf5876a8c9a87ac42024-03-03T06:25:12ZengWileyHemaSphere2572-92412023-08-017e944501b10.1097/01.HS9.0000971676.94450.1b202308003-01093P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA.Yuelu Guo0Kai Hu1Xiaoyan Ke2Teng Xu3Shaomei Feng4Peihao Zheng5Lixia MA6Fan Yang7Hui Shi8Biping Deng9Liu Rui10Zhonghua Fu111 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijinghttp://journals.lww.com/10.1097/01.HS9.0000971676.94450.1b |
| spellingShingle | Yuelu Guo Kai Hu Xiaoyan Ke Teng Xu Shaomei Feng Peihao Zheng Lixia MA Fan Yang Hui Shi Biping Deng Liu Rui Zhonghua Fu P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA. HemaSphere |
| title | P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA. |
| title_full | P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA. |
| title_fullStr | P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA. |
| title_full_unstemmed | P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA. |
| title_short | P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA. |
| title_sort | p1195 a prospective study of targeted sequential immunotherapy in patients with relapsed refractory primary mediastinal large b cell lymphoma |
| url | http://journals.lww.com/10.1097/01.HS9.0000971676.94450.1b |
| work_keys_str_mv | AT yueluguo p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT kaihu p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT xiaoyanke p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT tengxu p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT shaomeifeng p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT peihaozheng p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT lixiama p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT fanyang p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT huishi p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT bipingdeng p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT liurui p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT zhonghuafu p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma |